Vivosim Labs Stock Performance
| VIVS Stock | 2.02 0.10 5.21% |
The entity has a beta of 1.13, which indicates a somewhat significant risk relative to the market. VivoSim Labs returns are very sensitive to returns on the market. As the market goes up or down, VivoSim Labs is expected to follow. At this point, VivoSim Labs has a negative expected return of -0.4%. Please make sure to validate VivoSim Labs' potential upside and day median price , to decide if VivoSim Labs performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days VivoSim Labs has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
Actual Historical Performance (%)
One Day Return 5.21 | Five Day Return (11.79) | Year To Date Return 7.45 | Ten Year Return 17.44 | All Time Return 17.44 |
Last Split Factor 1:12 | Dividend Date 2020-08-19 | Last Split Date 2025-03-21 |
1 | How VivoSim Labs Inc. stock trades in high volatility - 2025 Short Interest Intraday High Probability Setup Alerts - newser.com | 10/31/2025 |
2 | NIO Stock Pops as EV Maker Smashes Delivery Record With 92 percent Surge | 11/04/2025 |
3 | Will VivoSim Labs Inc. stock beat revenue estimates - Trade Entry Report Verified Entry Point Signals - newser.com | 11/13/2025 |
4 | Onvo Kicks Off the Holidays with Free Coffee Thanksgiving Weekend and 99 Any Size Coffee All December Long | 11/21/2025 |
5 | Insider Trading | 11/24/2025 |
6 | Acquisition by Sethi Amar Akhtar of 53500 shares of VivoSim Labs, at 2.19 subject to Rule 16b-3 | 11/25/2025 |
7 | Why VivoSim Labs Inc. stock could outperform in 2025 - Market Risk Report Expert Verified Movement Alerts - B NI V | 11/26/2025 |
8 | 12 Health Care Stocks Moving In Fridays Pre-Market Session | 12/12/2025 |
9 | Global 3D Bioprinting Market Set to Reach USD 2.4 Billion by 2029 MarketsandMarkets | 01/08/2026 |
| Begin Period Cash Flow | 3 M | |
| Total Cashflows From Investing Activities | 9 M |
VivoSim Labs Relative Risk vs. Return Landscape
If you would invest 287.00 in VivoSim Labs on October 15, 2025 and sell it today you would lose (85.00) from holding VivoSim Labs or give up 29.62% of portfolio value over 90 days. VivoSim Labs is currently does not generate positive expected returns and assumes 6.0612% risk (volatility on return distribution) over the 90 days horizon. In different words, 54% of stocks are less volatile than VivoSim, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
VivoSim Labs Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for VivoSim Labs' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as VivoSim Labs, and traders can use it to determine the average amount a VivoSim Labs' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0664
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | VIVS |
Based on monthly moving average VivoSim Labs is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of VivoSim Labs by adding VivoSim Labs to a well-diversified portfolio.
VivoSim Labs Fundamentals Growth
VivoSim Stock prices reflect investors' perceptions of the future prospects and financial health of VivoSim Labs, and VivoSim Labs fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on VivoSim Stock performance.
| Return On Equity | -0.35 | ||||
| Return On Asset | -0.75 | ||||
| Operating Margin | (61.84) % | ||||
| Current Valuation | (5.46 M) | ||||
| Shares Outstanding | 2.6 M | ||||
| Price To Book | 0.47 X | ||||
| Price To Sales | 35.75 X | ||||
| Revenue | 144 K | ||||
| Gross Profit | (4.89 M) | ||||
| EBITDA | (2.21 M) | ||||
| Net Income | (2.49 M) | ||||
| Total Debt | 942 K | ||||
| Book Value Per Share | 5.53 X | ||||
| Cash Flow From Operations | (9.46 M) | ||||
| Earnings Per Share | (1.70) X | ||||
| Market Capitalization | 5.15 M | ||||
| Total Asset | 14.65 M | ||||
| Retained Earnings | (342.16 M) | ||||
| Working Capital | 8.39 M | ||||
About VivoSim Labs Performance
Assessing VivoSim Labs' fundamental ratios provides investors with valuable insights into VivoSim Labs' financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the VivoSim Labs is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 333.95 | 234.51 | |
| Return On Tangible Assets | (0.15) | (0.16) | |
| Return On Capital Employed | (1.33) | (1.40) | |
| Return On Assets | (0.15) | (0.16) | |
| Return On Equity | (0.27) | (0.26) |
Things to note about VivoSim Labs performance evaluation
Checking the ongoing alerts about VivoSim Labs for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for VivoSim Labs help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| VivoSim Labs generated a negative expected return over the last 90 days | |
| VivoSim Labs has high historical volatility and very poor performance | |
| VivoSim Labs has a very high chance of going through financial distress in the upcoming years | |
| VivoSim Labs was previously known as ONVO Old and was traded on NASDAQ Exchange under the symbol ONVO. | |
| The company reported the previous year's revenue of 144 K. Net Loss for the year was (2.49 M) with loss before overhead, payroll, taxes, and interest of (4.89 M). | |
| VivoSim Labs generates negative cash flow from operations | |
| VivoSim Labs has a very weak financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Global 3D Bioprinting Market Set to Reach USD 2.4 Billion by 2029 MarketsandMarkets |
- Analyzing VivoSim Labs' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether VivoSim Labs' stock is overvalued or undervalued compared to its peers.
- Examining VivoSim Labs' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating VivoSim Labs' management team can have a significant impact on its success or failure. Reviewing the track record and experience of VivoSim Labs' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of VivoSim Labs' stock. These opinions can provide insight into VivoSim Labs' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for VivoSim Stock Analysis
When running VivoSim Labs' price analysis, check to measure VivoSim Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VivoSim Labs is operating at the current time. Most of VivoSim Labs' value examination focuses on studying past and present price action to predict the probability of VivoSim Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VivoSim Labs' price. Additionally, you may evaluate how the addition of VivoSim Labs to your portfolios can decrease your overall portfolio volatility.